Related Experiment Video
Updated: Apr 18, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma
Olga Shakhova1, Phil Cheng2, Pravin J Mishra3
1Cell and Developmental Biology, Institute of Anatomy, University of Zurich, Zurich, Switzerland.
Abstract:
Melanoma is the most fatal skin cancer, but the etiology of this devastating disease is still poorly understood. Recently, the transcription factor Sox10 has been shown to promote both melanoma initiation and progression. Reducing SOX10 expression levels in human melanoma cells and in a genetic melanoma mouse model, efficiently abolishes tumorigenesis by inducing cell cycle exit and apoptosis. Here, we show that this anti-tumorigenic effect functionally involves SOX9, a factor related to SOX10 and upregulated in melanoma cells upon loss of SOX10. Unlike SOX10, SOX9 is not required for normal melanocyte stem cell function, the formation of hyperplastic lesions, and melanoma initiation. To the contrary, SOX9 overexpression results in cell cycle arrest, apoptosis, and a gene expression profile shared by melanoma cells with reduced SOX10 expression. Moreover, SOX9 binds to the SOX10 promoter and induces downregulation of SOX10 expression, revealing a feedback loop reinforcing the SOX10 low/SOX9 high ant,m/ii-tumorigenic program. Finally, SOX9 is required in vitro and in vivo for the anti-tumorigenic effect achieved by reducing SOX10 expression. Thus, SOX10 and SOX9 are functionally antagonistic regulators of melanoma development.
Insights
The transcription factor SOX10 promotes melanoma, while SOX9 suppresses it. SOX9 upregulation upon SOX10 loss creates a feedback loop, revealing SOX10 and SOX9 as antagonistic melanoma regulators.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Melanoma, a fatal skin cancer, has poorly understood etiology.
- The transcription factor SOX10 promotes melanoma initiation and progression.
- Reducing SOX10 expression halts melanoma tumorigenesis by inducing cell cycle exit and apoptosis.
Purpose of the Study:
- Investigate the role of SOX9 in the anti-tumorigenic effects of SOX10 reduction in melanoma.
- Elucidate the functional relationship between SOX10 and SOX9 in melanoma development.
Main Methods:
- Studied SOX9 expression and function in human melanoma cells and a genetic mouse model.
- Analyzed cell cycle, apoptosis, and gene expression profiles upon SOX9 manipulation.
- Investigated SOX9 binding to the SOX10 promoter and its effect on SOX10 expression.
- Assessed the necessity of SOX9 for SOX10-low mediated anti-tumorigenic effects.
Main Results:
- SOX9 is upregulated upon SOX10 loss and induces cell cycle arrest and apoptosis, similar to SOX10-low melanoma cells.
- SOX9 binds to the SOX10 promoter, downregulating SOX10 expression and creating a reinforcing feedback loop.
- SOX9 is essential for the anti-tumorigenic effects observed when SOX10 expression is reduced.
- Unlike SOX10, SOX9 is not required for normal melanocyte stem cell function or melanoma initiation.
Conclusions:
- SOX10 and SOX9 act as functionally antagonistic regulators in melanoma development.
- The SOX10 low/SOX9 high state represents an anti-tumorigenic program.
- Targeting this SOX10/SOX9 antagonism could offer novel therapeutic strategies for melanoma.
Related Concept Videos
Pleiotropy
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression

